LivaNova PLC
NASDAQ:LIVN

Watchlist Manager
LivaNova PLC Logo
LivaNova PLC
NASDAQ:LIVN
Watchlist
Price: 49.01 USD -4.15% Market Closed
Market Cap: 2.7B USD
Have any thoughts about
LivaNova PLC?
Write Note

Intrinsic Value

The intrinsic value of one LIVN stock under the Base Case scenario is 81.47 USD. Compared to the current market price of 49.01 USD, LivaNova PLC is Undervalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LIVN Intrinsic Value
81.47 USD
Undervaluation 40%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
LivaNova PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for LIVN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about LIVN?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about LivaNova PLC

Provide an overview of the primary business activities
of LivaNova PLC.

What unique competitive advantages
does LivaNova PLC hold over its rivals?

What risks and challenges
does LivaNova PLC face in the near future?

Has there been any significant insider trading activity
in LivaNova PLC recently?

Summarize the latest earnings call
of LivaNova PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for LivaNova PLC.

Provide P/S
for LivaNova PLC.

Provide P/E
for LivaNova PLC.

Provide P/OCF
for LivaNova PLC.

Provide P/FCFE
for LivaNova PLC.

Provide P/B
for LivaNova PLC.

Provide EV/S
for LivaNova PLC.

Provide EV/GP
for LivaNova PLC.

Provide EV/EBITDA
for LivaNova PLC.

Provide EV/EBIT
for LivaNova PLC.

Provide EV/OCF
for LivaNova PLC.

Provide EV/FCFF
for LivaNova PLC.

Provide EV/IC
for LivaNova PLC.

Show me price targets
for LivaNova PLC made by professional analysts.

What are the Revenue projections
for LivaNova PLC?

How accurate were the past Revenue estimates
for LivaNova PLC?

What are the Net Income projections
for LivaNova PLC?

How accurate were the past Net Income estimates
for LivaNova PLC?

What are the EPS projections
for LivaNova PLC?

How accurate were the past EPS estimates
for LivaNova PLC?

What are the EBIT projections
for LivaNova PLC?

How accurate were the past EBIT estimates
for LivaNova PLC?

Compare the revenue forecasts
for LivaNova PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of LivaNova PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of LivaNova PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of LivaNova PLC compared to its peers.

Compare the P/E ratios
of LivaNova PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing LivaNova PLC with its peers.

Analyze the financial leverage
of LivaNova PLC compared to its main competitors.

Show all profitability ratios
for LivaNova PLC.

Provide ROE
for LivaNova PLC.

Provide ROA
for LivaNova PLC.

Provide ROIC
for LivaNova PLC.

Provide ROCE
for LivaNova PLC.

Provide Gross Margin
for LivaNova PLC.

Provide Operating Margin
for LivaNova PLC.

Provide Net Margin
for LivaNova PLC.

Provide FCF Margin
for LivaNova PLC.

Show all solvency ratios
for LivaNova PLC.

Provide D/E Ratio
for LivaNova PLC.

Provide D/A Ratio
for LivaNova PLC.

Provide Interest Coverage Ratio
for LivaNova PLC.

Provide Altman Z-Score Ratio
for LivaNova PLC.

Provide Quick Ratio
for LivaNova PLC.

Provide Current Ratio
for LivaNova PLC.

Provide Cash Ratio
for LivaNova PLC.

What is the historical Revenue growth
over the last 5 years for LivaNova PLC?

What is the historical Net Income growth
over the last 5 years for LivaNova PLC?

What is the current Free Cash Flow
of LivaNova PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for LivaNova PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
LivaNova PLC

Current Assets 1.1B
Cash & Short-Term Investments 346.4m
Receivables 197.2m
Other Current Assets 549.6m
Non-Current Assets 1.4B
Long-Term Investments 18.1m
PP&E 220.9m
Intangibles 1B
Other Non-Current Assets 159.7m
Current Liabilities 324.4m
Accounts Payable 77.9m
Accrued Liabilities 163.2m
Other Current Liabilities 83.3m
Non-Current Liabilities 887.5m
Long-Term Debt 604.3m
Other Non-Current Liabilities 283.2m
Efficiency

Earnings Waterfall
LivaNova PLC

Revenue
1.2B USD
Cost of Revenue
-400.1m USD
Gross Profit
841.7m USD
Operating Expenses
-708.3m USD
Operating Income
133.4m USD
Other Expenses
-109.7m USD
Net Income
23.7m USD

Free Cash Flow Analysis
LivaNova PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

LIVN Profitability Score
Profitability Due Diligence

LivaNova PLC's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Positive Free Cash Flow
Positive 3-Years Revenue Growth
47/100
Profitability
Score

LivaNova PLC's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

LIVN Solvency Score
Solvency Due Diligence

LivaNova PLC's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Positive Net Debt
58/100
Solvency
Score

LivaNova PLC's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LIVN Price Targets Summary
LivaNova PLC

Wall Street analysts forecast LIVN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LIVN is 72.62 USD with a low forecast of 60.6 USD and a high forecast of 94.5 USD.

Lowest
Price Target
60.6 USD
24% Upside
Average
Price Target
72.62 USD
48% Upside
Highest
Price Target
94.5 USD
93% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LIVN?

Click here to dive deeper.

Dividends

LivaNova PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for LIVN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

LIVN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

LivaNova PLC Logo
LivaNova PLC

Country

United Kingdom

Industry

Health Care

Market Cap

2.7B USD

Dividend Yield

0%

Description

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. The firm is focused on the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems throughout the world. The firm operates through two segments: Cardiac Surgery and Neuromodulation. Its Cardiac Surgery Business Franchise (CS) is engaged in the development, production and sale of cardiac surgery products, including oxygenators, heart-lung machines, perfusion tubing systems, cannulae and other accessories used for extracorporeal circulation, systems for autologous blood transfusion and blood washing. Its Neuromodulation Business Franchise designs develops and markets neuromodulation-based medical devices for the treatment of epilepsy and difficult-to-treat depression (DTD) and obstructive sleep apnea.

Contact

London
20 Eastbourne Terrace
+442033250662.0
www.livanova.com

IPO

2015-10-19

Employees

3 000

Officers

Chief Financial Officer
Mr. Alex Shvartsburg
Senior VP, Chief Legal Officer & Company Secretary
Mr. Michael D. Hutchinson
CEO & Director
Mr. Vladimir A. Makatsaria
Senior Director of Investor Relations
Lindsey Little
Vice President of Corporate Communications
Deanna Wilke
Senior Vice President of Corporate Development & IT
Mr. Matthew Joseph Dodds III
Show More
President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement
Mr. Paul R. Buckman
President of Global Epilepsy
Ms. Stephanie Bolton
Chief Innovation Officer
Ahmet Tezel Ph.D.
President of Cardiopulmonary Business Unit
Mr. Franco Poletti
Show Less

See Also

Discover More
What is the Intrinsic Value of one LIVN stock?

The intrinsic value of one LIVN stock under the Base Case scenario is 81.47 USD.

Is LIVN stock undervalued or overvalued?

Compared to the current market price of 49.01 USD, LivaNova PLC is Undervalued by 40%.

Back to Top